BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Form 8-K — May 28, 2026
$BCLIForm 8-KItems 5.02, 7.01, 9.01Filed May 28, 2026, 4:05 PM ET0001104659-26-067474Original filing
Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI) appointed Peter J. Pitts, former Associate Commissioner of the U.S. Food & Drug Administration, to its Board of Directors effective May 25, 2026.
Key figures
- Board size increase
- 7 to 8
- Option grant shares
- 150000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.